9-(2-hydroxy-3-nonyl)adenine has been researched along with Glioma in 1 studies
9-(2-hydroxy-3-nonyl)adenine: specific inhibitor of adenosine deaminase
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamamoto, M | 1 |
| Suzuki, SO | 1 |
| Himeno, M | 1 |
1 other study available for 9-(2-hydroxy-3-nonyl)adenine and Glioma
| Article | Year |
|---|---|
The effects of dynein inhibition on the autophagic pathway in glioma cells.
Topics: Adenine; Amino Acids; Autophagy; Cell Line, Tumor; Dynactin Complex; Dyneins; Enzyme Inhibitors; Gli | 2010 |